anti CD19 CAR NK cells
2023-SR-834
Phase 1 mab active
Quick answer
anti CD19 CAR NK cells for Antisynthetase Syndrome is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Antisynthetase Syndrome
- Phase
- Phase 1
- Modality
- mab
- Status
- active